Results 61 to 70 of about 19,479 (205)

Guideline Recommendation for Endpoints Used in Clinical Trials for Functional Dyspepsia

open access: yesThe Korean Journal of Gastroenterology, 2018
Functional dyspepsia is a disease, in which there is no organic lesion but chronic and repetitive postprandial fullness, early satiation, epigastric pain, and epigastric burning. Functional dyspepsia is not life-threatening but its symptoms are relapsing
Han Hee Lee   +2 more
doaj   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

Prevalence and Risk Factors of Functional Dyspepsia: A Population-Based Study

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Background: Functional dyspepsia is one of the most common functional gastrointestinal disorders and affects more than 20% of the population. This study aimed to determine the prevalence of functional dyspepsia according to Rome IV criteria and its ...
Selami Aydın   +3 more
doaj   +1 more source

Review: Functional dyspepsia

open access: yesTherapeutic Advances in Gastroenterology, 2010
Dyspepsia is a common term used for a heterogeneous group of abdominal symptoms. Functional dyspepsia (FD) is the focus of this review. The 2006 Rome III criteria defined FD and its subgroups, postprandial distress syndrome (PDS) and epigastric pain ...
Rita Brun MD, Braden Kuo MD
doaj   +1 more source

Pathophysiology of functional dyspepsia [PDF]

open access: yesGut, 2002
Functional dyspepsia is a symptom complex characterised by postprandial upper abdominal discomfort or pain, early satiety, nausea, vomiting, abdominal distension, bloating, and anorexia in the absence of organic disease. Gastrointestinal motor abnormalities, altered visceral sensation, and psychosocial factors have all been identified as major ...
openaire   +3 more sources

The Effect of Central Sensitization on Long‐Term Prognosis and Comorbidity Levels in Temporomandibular Disorders: A Prospective Longitudinal Study

open access: yesJournal of Oral Rehabilitation, EarlyView.
Higher central sensitization‐related symptoms levels based on the Central Sensitization Inventory (CSI) predict greater psychological distress, sleep disturbance, autonomic dysfunction and reduced response to long‐term conservative treatment in temporomandibular disorders.
Seok Jin Lee   +4 more
wiley   +1 more source

Targeting Overweight and Obesity Phenotypes for Secondary Prevention of Cardiovascular Disease: A Call to Action for the Middle East and Beyond

open access: yesObesity Reviews, EarlyView.
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed   +19 more
wiley   +1 more source

GENERAL PRACTITIONERS KNOWLEDGE REGARDING FUNCTIONAL DYSPEPSIA

open access: yesPakistan Journal of Medicine and Dentistry, 2019
Background: Most researches on Gastrointestinal (GI) disorders are conducted in secondary health care settings, yet majority patients present at a primary health care level.
Farah Ahmad   +4 more
doaj  

The role of diet in the overlap between gastroesophageal reflux disease and functional dyspepsia

open access: yesThe Turkish Journal of Gastroenterology, 2016
Background/Aims: The prevalence of functional dyspepsia partially overlaps with gastroesophageal reflux disease (GERD), and this suggests common pathogenic mechanisms. The role of diet in these conditions is still under investigation.
Ioan Chirila   +3 more
doaj   +1 more source

Adaptations of glucagon‐like peptide‐1 receptor agonist‐induced weight loss, drivers of weight regain and future directions of therapeutics

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend During GLP‐1RA treatment reduced appetite and energy intake, delayed gastric emptying, decreased visceral fat mass and improved glycaemic control contribute to weight loss. After treatment cessation these benefits are partially or completely reversed, resulting in weight regain, accompanied by increased appetite and energy intake,
Camille E. M. Piguet   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy